OrthoPediatrics Corp. - Common Stock (KIDS)
Frequently Asked Questions About OrthoPediatrics Corp. - Common Stock (KIDS)
Does OrthoPediatrics Corp. participate in any charitable initiatives?
Yes, OrthoPediatrics Corp. actively participates in charitable initiatives and partnerships focused on improving healthcare outcomes for children. The company often collaborates with organizations dedicated to advancing pediatric orthopedic care and supporting families in need, reflecting its commitment to social responsibility.
How does OrthoPediatrics Corp. educate healthcare professionals about its products?
OrthoPediatrics Corp. educates healthcare professionals through a combination of training sessions, workshops, webinars, and hands-on product demonstrations. The company places a strong emphasis on providing surgeons and medical staff with the knowledge and skills necessary to effectively utilize their specialized orthopedic products.
How does OrthoPediatrics Corp. ensure the safety and efficacy of its products?
OrthoPediatrics Corp. ensures the safety and efficacy of its products through rigorous research and development, clinical trials, and compliance with regulatory standards. The company adheres to strict FDA regulations and guidelines, and engages with healthcare professionals to continually refine and improve its product offerings based on real-world feedback and results.
How is OrthoPediatrics Corp. addressing the challenges in pediatric orthopedic care?
OrthoPediatrics Corp. is addressing the challenges in pediatric orthopedic care by innovating customized solutions that specifically cater to the unique anatomical and physiological characteristics of children. By focusing on evidence-based design and collaboration with pediatric specialists, the company aims to improve treatment outcomes and provide better healthcare experiences for young patients.
Is OrthoPediatrics Corp. publicly traded?
Yes, OrthoPediatrics Corp. is publicly traded and is listed on the NASDAQ under the ticker symbol 'KIDS'. The company went public in 2019, enabling it to raise capital for further growth and development of its pediatric orthopedic product offerings.
What are OrthoPediatrics Corp.'s core value propositions?
OrthoPediatrics Corp.'s core value propositions include innovation, customization, and commitment to improving pediatric orthopedic care. The company aims to revolutionize the field by providing high-quality, specialized products that enhance surgical efficacy and patient outcomes, all designed with the unique needs of children in mind.
What are the long-term goals of OrthoPediatrics Corp.?
The long-term goals of OrthoPediatrics Corp. include further expanding its product portfolio, increasing market share in the pediatric orthopedic segment, and enhancing global reach. The company aims to continue driving innovation and improving surgical outcomes for children with orthopedic conditions, while also maximizing shareholder value.
What does OrthoPediatrics Corp. do?
OrthoPediatrics Corp. is a medical device company that focuses exclusively on the development and commercialization of orthopedic products for children and adolescents. The company designs innovative solutions for musculoskeletal disorders and injuries, with an emphasis on surgical procedures for treating conditions such as scoliosis, limb deformities, and fractures in pediatric patients.
What has been the growth trend of OrthoPediatrics Corp. since its founding?
Since its founding, OrthoPediatrics Corp. has experienced significant growth due to its niche focus on pediatric orthopedics and the increasing demand for specialized medical solutions for children. The company's innovative product introductions, strategic partnerships, and global expansion efforts have all contributed to its growth trajectory.
What is the significance of OrthoPediatrics being focused on pediatrics?
Being focused exclusively on pediatrics allows OrthoPediatrics to tailor its products to the specific needs of young patients, whose anatomical and physiological characteristics differ significantly from adults. This specialization helps ensure better outcomes, reduced complications, and improved surgical processes for conditions that are unique to children.
What is the typical process for a product launch at OrthoPediatrics?
The typical product launch process at OrthoPediatrics involves extensive market research, design and development, clinical trials, and collaboration with healthcare professionals. The company carefully evaluates feedback and real-world performance before officially introducing new products to ensure they meet the needs of pediatric surgeons and their patients.
What kind of research and development initiatives does OrthoPediatrics undertake?
OrthoPediatrics invests heavily in research and development to create innovative surgical solutions for pediatric orthopedic conditions. This includes collaborating with leading pediatric orthopedic surgeons, conducting clinical studies, and focusing on design improvements that prioritize the unique needs of younger patients and their caregivers.
What role does technology play in OrthoPediatrics' product development?
Technology plays a crucial role in OrthoPediatrics' product development by enabling the creation of advanced surgical instruments and implants that meet the specific needs of pediatric patients. The company leverages cutting-edge materials and design methodologies, as well as computer-aided design and manufacturing processes, to enhance the performance and safety of its products.
What types of musculoskeletal conditions does OrthoPediatrics target?
OrthoPediatrics targets a variety of musculoskeletal conditions, including scoliosis, limb deformities, fractures, and other orthopedic issues that require surgical intervention in children. Their products are designed to address both common and complex pediatric orthopedic challenges, enhancing surgical outcomes for young patients.
What types of products does OrthoPediatrics offer?
OrthoPediatrics offers a range of orthopedic products, including surgical implants and instruments specifically designed for pediatric use. Their product lines cover areas such as spinal deformity correction, trauma, and limb lengthening, among others, making them vital tools for pediatric orthopedic surgeons.
When was OrthoPediatrics Corp. founded?
OrthoPediatrics Corp. was founded in 2006. The company was established with the mission to address the unmet needs in orthopedic surgery for children by creating specialized instruments and implants that are tailored to the unique anatomical requirements of pediatric patients.
Where is OrthoPediatrics Corp. headquartered?
OrthoPediatrics Corp. is headquartered in Warsaw, Indiana, USA. This location serves as the central hub for the company’s operations, including product development, sales, and corporate management.
Who are OrthoPediatrics Corp.'s primary customers?
OrthoPediatrics Corp.'s primary customers include children's hospitals, orthopedic surgical centers, and pediatric orthopedic surgeons who treat musculoskeletal conditions in children. These customers rely on the company's specialized products to provide effective and safe surgical options for their young patients.
Who are some of the key competitors of OrthoPediatrics Corp.?
Key competitors of OrthoPediatrics Corp. include established medical device companies that offer orthopedic products for pediatric care, such as Stryker, Zimmer Biomet, and Depuy Synthes. However, OrthoPediatrics differentiates itself by concentrating exclusively on the pediatric market, allowing for tailored and specialized offerings.
What is the current price of OrthoPediatrics Corp. - Common Stock?
The current price of OrthoPediatrics Corp. - Common Stock is 22.76
When was OrthoPediatrics Corp. - Common Stock last traded?
The last trade of OrthoPediatrics Corp. - Common Stock was at 4:00 pm EDT on July 24th, 2025
What is the market capitalization of OrthoPediatrics Corp. - Common Stock?
The market capitalization of OrthoPediatrics Corp. - Common Stock is 447.75M
How many shares of OrthoPediatrics Corp. - Common Stock are outstanding?
OrthoPediatrics Corp. - Common Stock has 19.67M shares outstanding.